AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2021
May 27, 2021
32853_dirs_2021-05-27_e1bc8003-453d-4816-a5c7-9305d6b8fd13.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2021-05-25
Reporting Person: Burbach Gerhard F (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-25 | Common Stock | A | 10342 | — | Acquired | 65913 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-25 | Stock Option (Right to Buy) | $5.56 | A | 15402 | Acquired | 2031-05-25 | Common Stock (15402.0) | Direct |
Footnotes
F1: The Restricted Stock Units vest in full on the earlier to occur of May 25, 2022 and one day prior to the date of the Company's next annual meeting of stockholders.
F2: Includes 34,202 vested Restricted Stock Units with respect to which the Reporting Person has deferred settlement. Vested shares will be delivered to the Reporting Person within thirty days following the earlier to occur of a change in control and the Reporting Person's termination of service.
F3: The Option becomes exercisable in twelve equal monthly increments beginning on June 25, 2021.